Current:Home > NewsEli Lilly says an experimental drug slows Alzheimer's worsening-LoTradeCoin
Eli Lilly says an experimental drug slows Alzheimer's worsening
View Date:2024-12-23 19:26:17
WASHINGTON — Eli Lilly and Co. said Wednesday its experimental Alzheimer's drug appeared to slow worsening of the mind-robbing disease in a large study.
In the 18-month trial, people in the early stages of Alzheimer's who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug, Lilly announced in a press release.
The drug is designed to target and clear away a sticky protein called beta-amyloid that builds up into brain-clogging plaques that are one hallmark of Alzheimer's.
A similar amyloid-targeting drug, Eisai and Biogen's Leqembi, recently hit the market with similar evidence that it could modestly slow Alzheimer's — and also some safety concerns, brain swelling or small brain bleeds.
Donanemab also comes with that risk. Lilly said in its study, the brain side effects caused the deaths of two participants and a third also died after a serious case.
The preliminary study results haven't been vetted by outside experts. Indianapolis-based Lilly plans to release more details at an international Alzheimer's meeting this summer and is seeking Food and Drug Administration approval of the drug.
veryGood! (52)
Related
- Does the NFL have a special teams bias when hiring head coaches? History indicates it does
- Biden tells Americans we have to bring the nation together in Thanksgiving comments
- Argentina and Brazil charged by FIFA after fan violence delays World Cup qualifying game at Maracana
- Runaway bull on Phoenix freeway gets wrangled back without injury
- Dwayne 'The Rock' Johnson weighs in on report that he would 'pee in a bottle' on set
- Oprah's Favorite Things 2023: Cute, Cozy & Chic Small Business Finds on Amazon
- This mom nearly died. Now she scrubs in to the same NICU where nurses cared for her preemie
- The eight best college football games to watch in Week 13 starts with Ohio State-Michigan
- Texas now tops in SEC? Miami in trouble? Five overreactions to college football Week 11
- FDA expands cantaloupe recall after salmonella infections double in a week
Ranking
- The ancient practice of tai chi is more popular than ever. Why?
- 6-year-old Mississippi girl honored for rescue efforts after her mother had a stroke while driving
- Nice soccer player Atal will face trial Dec. 18 after sharing an antisemitic message on social media
- Commuter train strikes and kills man near a Connecticut rail crossing
- Biden, Harris participate in Veterans Day ceremony | The Excerpt
- AI drama over as OpenAI CEO Sam Altman is reinstated with help from Microsoft
- Putin’s first prime minister and later his opponent has been added to Russia’s ‘foreign agent’ list
- 4 Black Friday shopping tips to help stretch your holiday budget
Recommendation
-
Chipotle unveils cilantro-scented soap, 'water' cup candles in humorous holiday gift line
-
South Carolina basketball sets program record in 101-19 rout of Mississippi Valley State
-
Horoscopes Today, November 23, 2023
-
Georgia high school baseball player in coma after batting cage accident
-
Fire crews on both US coasts battle wildfires, 1 dead; Veterans Day ceremony postponed
-
This designer made the bodysuit Beyoncé wears in 'Renaissance' film poster
-
Putin to boost AI work in Russia to fight a Western monopoly he says is ‘unacceptable and dangerous’
-
The Best Dyson Black Friday Deals of 2023: Score $100 Off the Airwrap & More